Effect of dexamethasone (DEX) dose modification on osteonecrosis (ON) risk associated with intensified therapies for standard risk acute lymphoblastic leukemia (SR-ALL): A report from the Children’s Oncology Group (COG) study AALL0331.
Leonard A. Mattano
No relevant relationships to disclose
Meenakshi Devidas
No relevant relationships to disclose
Alison M. Friedmann
No relevant relationships to disclose
Elizabeth A. Raetz
No relevant relationships to disclose
Stephen Hunger
No relevant relationships to disclose
Naomi Joan Winick
No relevant relationships to disclose
William L. Carroll
No relevant relationships to disclose
Kelly W. Maloney
No relevant relationships to disclose